The Effect of the Adoption of the National Accreditation Program for Rectal Cancer Process on Compliance Standards at a Single Institution
<b>Background:</b> The National Accreditation Program for Rectal Cancer (NAPRC) was developed to enhance the quality of rectal cancer care in the United States. This project compared NAPRC compliance at a single tertiary care academic hospital before and after the institution adopted these standards in 2019. <b>Methods:</b> Rectal cancer patients from 2016 to 2023 who met NAPRC eligibility criteria were retrospectively reviewed for compliance with pre-selected patient care standards. Patients diagnosed prior to August 1, 2019 (pre-NAPRC) were compared with those diagnosed afterward (post-NAPRC) to determine whether compliance with these standards differed following the institution's adoption of new guidelines. <b>Results:</b> This study included 353 patients, 146 pre-NAPRC and 207 post-NAPRC. The post-NAPRC group demonstrated significantly higher compliance with pretreatment standards compared to the pre-NAPRC group, including attaining magnetic resonance imaging (MRI) (<i>P</i> = .015), computed tomography (CT) (<i>P</i> < .001), and a carcinoembryonic antigen (CEA) level (<i>P</i> < .001). Postoperative standards were more frequently met in the post-NAPRC group regarding the photographing of surgical specimens (<i>P</i> < .001). No significant differences were observed in confirming a tissue diagnosis, starting treatment within a 60-day timeframe, or completing surgical pathology reports. Prior to initiation of the NAPRC process, the institution had achieved accreditation-level compliance in 2 of the 7 standards. Within 2 years of adopting NAPRC standards, complete compliance was met in 6 of the 7 measures. <b>Conclusions:</b> A single institution's adoption of NAPRC standards improved compliance with multiple rectal cancer care standards, achieving near-complete accreditation level compliance within 2 years.
Authors
- Forrest Bohler (ORCID: https://orcid.org/0000-0002-9963-2213)
- Harry Wasvary (ORCID: https://orcid.org/0000-0003-4178-6890)
- Shelli Bergeron (ORCID: https://orcid.org/0000-0001-9442-9251)
- Gregory J. Thomas
- Garrett W. Peters (ORCID: https://orcid.org/0009-0007-9286-2175)
- Jacob Applegarth
- Rose E. Callahan (ORCID: https://orcid.org/0000-0003-1156-7240)
- Joanna Wasvary
Institutions
- Oakland University (US)
- Beaumont Hospital, Royal Oak (US)
Publication Details
- Journal
- The American Surgeon
- Published
- 2024-10-14
- DOI
- https://doi.org/10.1177/00031348241292730
- Citations
- 2
- Primary Topic
- Colorectal Cancer Surgical Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.57